- Home
- IVR vs VERV Comparison
IVR vs VERV Comparison
Compare IVR & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVR
- VERV
- Stock Information
- Founded
- IVR 2008
- VERV 2018
- Country
- IVR United States
- VERV United States
- Employees
- IVR N/A
- VERV N/A
- Industry
- IVR Real Estate Investment Trusts
- VERV Medicinal Chemicals and Botanical Products
- Sector
- IVR Real Estate
- VERV Health Care
- Exchange
- IVR Nasdaq
- VERV Nasdaq
- Market Cap
- IVR 493.1M
- VERV 475.0M
- IPO Year
- IVR 2009
- VERV 2021
- Fundamental
- Price
- IVR $8.56
- VERV $8.48
- Analyst Decision
- IVR Buy
- VERV Strong Buy
- Analyst Count
- IVR 3
- VERV 4
- Target Price
- IVR N/A
- VERV $25.75
- AVG Volume (30 Days)
- IVR 1.2M
- VERV 1.7M
- Earning Date
- IVR 02-20-2025
- VERV 02-25-2025
- Dividend Yield
- IVR 18.96%
- VERV N/A
- EPS Growth
- IVR N/A
- VERV N/A
- EPS
- IVR 1.23
- VERV N/A
- Revenue
- IVR $102,893,000.00
- VERV $24,396,000.00
- Revenue This Year
- IVR N/A
- VERV $106.46
- Revenue Next Year
- IVR $8.53
- VERV N/A
- P/E Ratio
- IVR $6.93
- VERV N/A
- Revenue Growth
- IVR 654.96
- VERV 219.91
- 52 Week Low
- IVR $7.48
- VERV $4.31
- 52 Week High
- IVR $9.97
- VERV $19.34
- Technical
- Relative Strength Index (RSI)
- IVR 61.69
- VERV 65.78
- Support Level
- IVR $8.10
- VERV $6.95
- Resistance Level
- IVR $8.53
- VERV $7.98
- Average True Range (ATR)
- IVR 0.16
- VERV 0.68
- MACD
- IVR 0.06
- VERV 0.10
- Stochastic Oscillator
- IVR 97.64
- VERV 86.71
About IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.